Monitor the ASTRO meeting (Sept 26-30) for any data readouts from the poster presentation, which could provide incremental insights into aglatimagene's immune activation profile. No immediate trading catalyst.
Price Chart
Executive Summary
Candel Therapeutics announced that an abstract on aglatimagene besadenovec in localized prostate cancer was accepted for a poster presentation at the 2026 ASTRO Annual Meeting. No new clinical data or regulatory milestones were disclosed — this is a routine conference participation update with no material financial impact.
Key Facts
- Abstract accepted for poster presentation at ASTRO 2026 (Sept 26-30, Boston).
- Poster titled 'Quantitative Digital Pathology Defines Immune Activation Following Aglatimagene Besadenovec Immunotherapy in Localized Prostate Cancer'.
- No new clinical data, regulatory decisions, or financial guidance provided.
Financial Impact
No financial impact from this announcement.
Risk Factors
- No new data disclosed; abstract acceptance does not change the clinical or regulatory outlook.
- Stock may be subject to binary event risk around future pivotal data readouts or FDA decisions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3337474 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | Press Release | $10.16 | awaiting T+60 | — | $7.79 (−23.33%) |
Sep 30, 2026 27d ago | Press Release | $10.44 | awaiting T+60 | — | $7.79 (−25.38%) |
Sep 10, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Sep 9, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Aug 15, 2026 10w ago | Institutional Cluster | $12.16 | awaiting T+60 | — | $7.79 (−35.94%) |
Aug 13, 2026 10w ago | 8-K | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 13, 2026 10w ago | Press Release | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 3, 2026 12w ago | Press Release | $10.07 $8.16 | ▼ −18.97% | ▼ −20.75% | $7.79 (−22.64%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers